Prophylactic blood component therapy, “a saviour for obstetric patients at high risk for coagulopathy”
Journal Title: INTERNATIONAL JOURNAL OF CURRENT RESEARCH - Year 2018, Vol 10, Issue 5
Abstract
Background: Prophylactic blood component therapy, “A saviour for obstetric patients with non overt DIC”. {Dr Neena Gupta, Dr Shaily Agarwal, Dr Apurva Agarwal, Uruj jahan,Fatima Usmani, Poonam) Aims: To evaluate the role of prophylactic blood component therapy in nonovert DIC patients to reduce maternal morbidity and mortality. Methodology: This study was conducted on total 274indoor obstetric patients in the Department of Obstetrics & Gynaecology of UISEMH Kanpur from January 2016 to August 2017. Results: In Group IB, majority were managed in ward (72.41%) only 13.79 % patients required ICU care but mortality was nil. While in group IA 20.63% needed ICU care and mortality was 1.59%. In group II (overt DIC) all required ICU care and mortality was 59.38%. Patients in group IB (prophylactic blood component therapy) had shorter duration of hospital stay as compared to group IA and II. 40.18% in group II (overt DIC), 33.92% in group IA and 6.92 % in group IB patients had hospital stay for more than 10 days. Conclusion: Prophylactic blood component therapy corrected the coagulation abnormality and prevented them from landing up into established DIC.
Authors and Affiliations
Neena Gupta,1Shaily Agarwal Uruj Jahan, Fatima Usmani and Poonam Verma, Dr. Apurva Agarwal
Keywords
Related Articles
- EP ID EP403554
- DOI -
- Views 93
- Downloads 0
Effects of chemical developer depletion on insight and ektaspeed plus films: A sensitometric comparison
Objectives: To compare the sensitometric properties of Insight (F-SPEED) and Ektaspeed Plus radiographic (E-speed) film which was manually and automatically processed using fresh and depleted chemical solutions. Methods:...
An interventional study to ensure timeliness of nutritional assessment among spinal cord injured patients at tertiary care hospital in India
In order to ensure compliance to nutritional screening & its documentation as nutritional assessment form within 24 hours of patient’s admission, a prospective, longitudinal study was conducted wherein medical records of...
Imatinib induced sweet syndrome in the patient of chronic myeloid leukemia
Imatinib mesylate is the first line tyrosine kinase inhibitor and the main chemotherapeutic agents currently used to treat patients with chronic myeloid leukemia (CML). Although various cutaneous reactions to this drug a...
Comparative interventional study to assess the effectiveness of alternative hot and cold compresses vs. cold cabbage leaves on breast engorgement and pain among postnatal mothers
Comparative interventional study to assess the effectiveness of alternative hot & cold compresses vs. Cold cabbage leaves on breast engorgement and pain among postnatal mothers. This study was carried out to assess the e...
Critical analysis of biomarkers in periodontal practice : a brief review
Background: Early diagnosis and treatment of progressive periodontitis is important because of the irreversible nature of periodontal disease. . In the field of periodontology, traditional clinical criteria are often ins...